10.08.2020 | main topic
Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients
Results from a real-life patient cohort
Mario Karolyi, Erich Pawelka, Theresa Mader, Sara Omid, Hasan Kelani, Sarah Ely, Bernd Jilma, Sebastian Baumgartner, Hermann Laferl, Clemens Ott, Marianna Traugott, Michael Turner, Tamara Seitz, Christoph Wenisch, Alexander Zoufaly
03.02.2021 | original article
Methylprednisolone in adults hospitalized with COVID-19 pneumonia
An open-label randomized trial (GLUCOCOVID)
Luis Corral-Gudino, Alberto Bahamonde, Francisco Arnaiz-Revillas, Julia Gómez-Barquero, Jesica Abadía-Otero, Carmen García-Ibarbia, Víctor Mora, Ana Cerezo-Hernández, José L. Hernández, Graciela López-Muñíz, Fernando Hernández-Blanco, Jose M. Cifrián, Jose M. Olmos, Miguel Carrascosa, Luis Nieto, María Carmen Fariñas, José A. Riancho, GLUCOCOVID investigators
Open Access
09.12.2020 | original article
6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
Florian Deisenhammer MD, Wegene Borena MD, Angelika Bauer, Janine Kimpel PhD, MD, Dagmar Rudzki, Kathrin Schanda, Jonas Egeter PhD, Katharina Hüfner MD, Barbara Sperner-Unterweger MD, Markus Reindl PhD
26.11.2020 | review article
Clinical manifestations of COVID-19 in the general population: systematic review
Rodrigo da Rosa Mesquita, Luiz Carlos Francelino Silva Junior, Fernanda Mayara Santos Santana, Tatiana Farias de Oliveira, Rafaela Campos Alcântara, Gabriel Monteiro Arnozo, Etvaldo Rodrigues da Silva Filho, Aisla Graciele Galdino dos Santos, Euclides José Oliveira da Cunha, Saulo Henrique Salgueiro de Aquino, Carlos Dornels Freire de Souza
20.11.2020 | short report
A retrospective comparison between influenza and COVID-19-associated ARDS in a Croatian tertiary care center
Branimir Gjurašin MD, assistant professor Marija Santini MD, PhD, Vladimir Krajinović MD, PhD, Neven Papić MD, PhD, Anita Atelj MD, Viktor Kotarski MD, Juraj Krznarić MD, Martina Vargović MD, assistant professor Marko Kutleša MD, PhD